Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases
Authors
Keywords
-
Journal
Clinical and Molecular Hepatology
Volume 28, Issue 3, Pages 425-472
Publisher
The Korean Association for the Study of the Liver
Online
2022-07-07
DOI
10.3350/cmh.2022.0186
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Statin Use and Reduced Hepatocellular Carcinoma Risk in Patients with Non-alcoholic Fatty Liver Disease
- (2022) Biyao Zou et al. Clinical Gastroenterology and Hepatology
- Hepatitis B, C and D virus infections and risk of hepatocellular carcinoma in Africa: A meta-analysis including sensitivity analyses for studies comparable for confounders
- (2022) Donatien Serge Mbaga et al. PLoS One
- Effects of Branched-Chain Amino Acids on Parameters Evaluating Sarcopenia in Liver Cirrhosis: Systematic Review and Meta-Analysis
- (2022) Abdulrahman Ismaiel et al. Frontiers in Nutrition
- Aspirin Use and the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B Virus or Hepatitis C Virus Infection: A Meta-Analysis of Cohort Studies
- (2021) Xiaofei Li et al. Frontiers in Medicine
- Diagnosis and Management of Hepatic Encephalopathy
- (2021) Marika Rudler et al. Clinics in Liver Disease
- Ursodeoxycholic acid impairs liver‐infiltrating T cell chemotaxis through IFNγ and CX3CL1 production in primary biliary cholangitis
- (2021) Shin Shimoyama et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Aspirin Reduces the Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Receiving Oral Nucleos(t)ide Analog
- (2021) Vicki Wing-Ki Hui et al. Clinical and Translational Gastroenterology
- Systematic review with meta‐analysis: The effects of non‐steroidal anti‐inflammatory drugs and anti‐platelet therapy on the incidence and recurrence of hepatocellular carcinoma
- (2021) Regina Zi Hwei Tan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review with network meta‐analysis: comparative efficacy of pharmacologic therapies for fibrosis improvement and resolution of NASH
- (2021) Abdul M. Majzoub et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Association of aspirin and statin use with the risk of liver cancer in chronic hepatitis B: A nationwide population‐based study
- (2021) Won‐Mook Choi et al. LIVER INTERNATIONAL
- KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
- (2021) Seong Hee Kang et al. Clinical and Molecular Hepatology
- L‐ornithine L ‐aspartate in acute treatment of severe hepatic encephalopathy: A double‐blind randomized controlled trial
- (2021) Arpan Jain et al. HEPATOLOGY
- Gut Microbes and Hepatic Encephalopathy: From the Old Concepts to New Perspectives
- (2021) Alba Rocco et al. Frontiers in Cell and Developmental Biology
- Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis
- (2021) Kaneez Fatima et al. Clinics and Research in Hepatology and Gastroenterology
- Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study
- (2020) Yen-Hsiang Liao et al. BMC GASTROENTEROLOGY
- Synbiotic Alters Fecal Microbiomes, but not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Non-alcoholic Fatty Liver Disease
- (2020) Eleonora Scorletti et al. GASTROENTEROLOGY
- Nonalcoholic fatty liver disease: modulating gut microbiota to improve severity?
- (2020) Judith Aron-Wisnewsky et al. GASTROENTEROLOGY
- Association of Daily Aspirin Therapy with Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis C Virus Infection
- (2020) Teng-Yu Lee et al. Clinical Gastroenterology and Hepatology
- Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality
- (2020) Tracey G. Simon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Branched-Chain Amino Acid (BCAA) Supplementation on the Progression of Advanced Liver Disease: A Korean Nationwide, Multicenter, Prospective, Observational, Cohort Study
- (2020) Jung Gil Park et al. Nutrients
- Late Evening Snack with Branched-Chain Amino Acids Supplementation Improves Survival in Patients with Cirrhosis
- (2020) Tatsunori Hanai et al. Journal of Clinical Medicine
- Ursodeoxycholic acid alleviates nonalcoholic fatty liver disease by inhibiting apoptosis and improving autophagy via activating AMPK
- (2020) Pengbo Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trial
- (2020) Muhammad Amjad Pervez et al. COMPLEMENTARY THERAPIES IN MEDICINE
- Effects of Statin Use on the Development and Progression of Nonalcoholic Fatty Liver Disease
- (2020) Jung Il Lee et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Leaky Gut and Gut-Liver Axis in Liver Cirrhosis: Clinical Studies Update
- (2020) Hiroshi Fukui Gut and Liver
- Systematic review with meta‐analysis: The effect of vitamin E supplementation in adult patients with non‐alcoholic fatty liver disease
- (2020) Andreas Vadarlis et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Anti-fibrotic effects of branched-chain amino acids on hepatic stellate cells
- (2020) Hae Lim Lee et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
- (2020) Na Young Lee et al. Clinical and Molecular Hepatology
- Impact of Silymarin in individuals with nonalcoholic fatty liver disease: A systematic review and meta-analysis
- (2020) Georgios Kalopitas et al. NUTRITION
- Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
- (2019) Teng-Yu Lee et al. JAMA Internal Medicine
- Daily aspirin use associated with reduced risk for fibrosis progression in patients with nonalcoholic fatty liver disease
- (2019) Tracey G. Simon et al. Clinical Gastroenterology and Hepatology
- Treatment options for nonalcoholic fatty liver disease
- (2019) Amir Anushiravani et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection
- (2019) Shih-Hao Young et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Response by Ward et al to Letter Regarding Article, “Statin Toxicity: Mechanistic Insights and Clinical Implications”
- (2019) N.C. Ward et al. CIRCULATION RESEARCH
- Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
- (2019) Fernando Bril et al. DIABETES CARE
- Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease
- (2019) Sang Bong Ahn et al. Scientific Reports
- Aspirin targets P4HA2 through inhibiting NF-κB and LMCD1-AS1/let-7g to inhibit tumour growth and collagen deposition in hepatocellular carcinoma
- (2019) Tianjiao Wang et al. EBioMedicine
- Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial
- (2019) Stefan Traussnigg et al. Lancet Gastroenterology & Hepatology
- Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis
- (2019) Andrew M. Moon et al. Clinical Gastroenterology and Hepatology
- Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial
- (2019) Victor J. Navarro et al. PLoS One
- Systematic Review with Meta-Analysis: The Effects of Probiotics in Nonalcoholic Fatty Liver Disease
- (2019) Meng-Wei Xiao et al. Gastroenterology Research and Practice
- Harms Reporting in Randomized Controlled Trials of Interventions Aimed at Modifying Microbiota
- (2018) Aïda Bafeta et al. ANNALS OF INTERNAL MEDICINE
- Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease
- (2018) Roger F. Butterworth et al. DIGESTIVE DISEASES
- A multi-strain probiotic reduces the fatty liver index, cytokines and aminotransferase levels in NAFLD patients: evidence from a randomized clinical trial
- (2018) Journal of Gastrointestinal and Liver Diseases
- Correction of intrahepatic microcirculation disorders by L-ornithine-L-aspartate at the chronic liver diseases patients
- (2018) T. Ermolova et al. JOURNAL OF HEPATOLOGY
- Urea cycle dysregulation in non-alcoholic fatty liver disease
- (2018) Francesco De Chiara et al. JOURNAL OF HEPATOLOGY
- Ammonia: A novel target for the treatment of non-alcoholic steatohepatitis
- (2018) Karen Louise Thomsen et al. MEDICAL HYPOTHESES
- Statins: pros and cons
- (2018) Iago Pinal-Fernandez et al. MEDICINA CLINICA
- Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
- (2018) Mario Masarone et al. Oxidative Medicine and Cellular Longevity
- Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases
- (2018) Keith D. Lindor et al. HEPATOLOGY
- Intestinal Microbiota Modulation in Obesity-Related Non-alcoholic Fatty Liver Disease
- (2018) David Porras et al. Frontiers in Physiology
- Association Between Aspirin Use and Risk of Hepatocellular Carcinoma
- (2018) Tracey G. Simon et al. JAMA Oncology
- Branched chain amino acids supplementation modulates TGF-β1/Smad signaling pathway and interleukins in CCl4 -induced liver fibrosis
- (2017) Naglaa F. Khedr et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Antiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment
- (2017) Minjong Lee et al. HEPATOLOGY
- Ursodeoxycholic acid attenuates experimental autoimmune arthritis by targeting Th17 and inducing pAMPK and transcriptional corepressor SMILE
- (2017) Eun-Jung Lee et al. IMMUNOLOGY LETTERS
- Treatment efficacy of a probiotic preparation for non-alcoholic steatohepatitis: A pilot trial
- (2017) Elina Manzhalii et al. Journal of Digestive Diseases
- The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups
- (2017) Shiv Chitturi et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
- (2017) Gideon M. Hirschfield et al. JOURNAL OF HEPATOLOGY
- Ursodeoxycholic acid: Effects on hepatic unfolded protein response, apoptosis and oxidative stress in morbidly obese patients
- (2017) Michaela Mueller et al. LIVER INTERNATIONAL
- Silibinin Restores NAD+ Levels and Induces the SIRT1/AMPK Pathway in Non-Alcoholic Fatty Liver
- (2017) Federico Salomone et al. Nutrients
- Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model
- (2017) Kai Takegoshi et al. Oncotarget
- The Effect of Synbiotic Supplementation on Body Composition and Lipid Profile in Patients with NAFLD: A Randomized, Double Blind, Placebo-Controlled Clinical Trial Study
- (2017) Atefe Asgharian et al. Iranian Red Crescent Medical Journal
- A morphological method for ammonia detection in liver
- (2017) Virginia Gutiérrez-de-Juan et al. PLoS One
- Aspirin use is associated with lower indices of liver fibrosis among adults in the United States
- (2016) Z. Gordon Jiang et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study
- (2016) Yi-Wen Huang et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Antiplatelet Therapy is Associated with a Better Prognosis for Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma after Liver Resection
- (2016) Pei-Chang Lee et al. ANNALS OF SURGICAL ONCOLOGY
- Ursodeoxycholic acid decreases age-related adiposity and inflammation in mice
- (2016) Ah-Reum Oh et al. BMB Reports
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) et al. DIABETOLOGIA
- Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C–Related Compensated Cirrhosis
- (2016) Arpan Mohanty et al. GASTROENTEROLOGY
- Gut microbiome and liver diseases
- (2016) Herbert Tilg et al. GUT
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Effects of in-hospital exercise on liver function, physical ability, and muscle mass during treatment of hepatoma in patients with chronic liver disease
- (2016) Shunji Koya et al. HEPATOLOGY RESEARCH
- Statins for Prevention of Cardiovascular Disease in Adults
- (2016) Roger Chou et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Do symbiotic and Vitamin E supplementation have favorite effects in nonalcoholic fatty liver disease? A randomized, double-blind, placebo-controlled trial
- (2016) Farzad Shidfar et al. Journal of Research in Medical Sciences
- Hepatotoxicity of statins and other lipid-lowering agents
- (2016) Einar S. Björnsson LIVER INTERNATIONAL
- Targeting Dysbiosis for the Treatment of Liver Disease
- (2016) Gobind Anand et al. SEMINARS IN LIVER DISEASE
- An open-label randomized control study to compare the efficacy of vitamin e versus ursodeoxycholic acid in nondiabetic and noncirrhotic Indian NAFLD patients
- (2016) Pathik Parikh et al. Saudi Journal of Gastroenterology
- Silymarin Ameliorates Metabolic Dysfunction Associated with Diet-Induced Obesity via Activation of Farnesyl X Receptor
- (2016) Ming Gu et al. Frontiers in Pharmacology
- NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project
- (2015) J. L. Petrick et al. Cancer Prevention Research
- A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins
- (2015) Joseph L. Goldstein et al. CELL
- Improvement of Nonalcoholic Fatty Liver Disease With Carnitine-Orotate Complex in Type 2 Diabetes (CORONA): A Randomized Controlled Trial
- (2015) Ji Cheol Bae et al. DIABETES CARE
- Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: A randomized controlled trial
- (2015) Priscila Pollo-Flores et al. DIGESTIVE AND LIVER DISEASE
- Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES
- (2015) Adeel A. Butt et al. HEPATOLOGY
- Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity
- (2015) Michaela Mueller et al. JOURNAL OF HEPATOLOGY
- Statin use and non-alcoholic steatohepatitis in at risk individuals
- (2015) Paola Dongiovanni et al. JOURNAL OF HEPATOLOGY
- Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C
- (2015) Tracey G. Simon et al. JOURNAL OF HEPATOLOGY
- Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis
- (2015) John Chen Hsiang et al. JOURNAL OF HEPATOLOGY
- Statin use and the risk of cirrhosis development in patients with hepatitis C virus infection
- (2015) Yao-Hsu Yang et al. JOURNAL OF HEPATOLOGY
- Sarcopenia impairs prognosis of patients with liver cirrhosis
- (2015) Tatsunori Hanai et al. NUTRITION
- Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome
- (2015) Konstantinos Kargiotis WORLD JOURNAL OF GASTROENTEROLOGY
- Efficacy of Lifestyle Changes in Subjects with Non-Alcoholic Liver Steatosis and Metabolic Syndrome May Be Improved with an Antioxidant Nutraceutical: A Controlled Clinical Study
- (2015) Gianpaolo Sorrentino et al. Drugs in research & development
- Bifidobacterium pseudocatenulatum CECT 7765 Reduces Obesity-Associated Inflammation by Restoring the Lymphocyte-Macrophage Balance and Gut Microbiota Structure in High-Fat Diet-Fed Mice
- (2015) Angela Moya-Pérez et al. PLoS One
- Association between aspirin use and the prevalence of nonalcoholic fatty liver disease: a cross-sectional study from the Third National Health and Nutrition Examination Survey
- (2014) H. Shen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study
- (2014) Tannaz Eslamparast et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Metabolic Activation of Intrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes
- (2014) Monika Julia Wolf et al. CANCER CELL
- Statin Use in Patients with Cirrhosis: A Retrospective Cohort Study
- (2014) Sonal Kumar et al. DIGESTIVE DISEASES AND SCIENCES
- A systematic review of the safety of probiotics
- (2014) Tina Didari et al. Expert Opinion On Drug Safety
- Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy
- (2014) Qing Jiang FREE RADICAL BIOLOGY AND MEDICINE
- Probiotic VSL#3 Reduces Liver Disease Severity and Hospitalization in Patients With Cirrhosis: A Randomized, Controlled Trial
- (2014) Radha K. Dhiman et al. GASTROENTEROLOGY
- Extrahepatic Platelet-Derived Growth Factor-β, Delivered by Platelets, Promotes Activation of Hepatic Stellate Cells and Biliary Fibrosis in Mice
- (2014) Shuhei Yoshida et al. GASTROENTEROLOGY
- Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease
- (2014) S. Nabavi et al. JOURNAL OF DAIRY SCIENCE
- Effect of carnitine-orotate complex on glucose metabolism and fatty liver: A double-blind, placebo-controlled study
- (2014) Eun Shil Hong et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Pharmacological potential of tocotrienols: a review
- (2014) Haseeb Ahsan et al. Nutrition & Metabolism
- Serum Oxidative Stress Markers and Lipidomic Profile to Detect NASH Patients Responsive to an Antioxidant Treatment: A Pilot Study
- (2014) Paola Stiuso et al. Oxidative Medicine and Cellular Longevity
- Protective Efficacy of Vitamins C and E on p,p′-DDT-Induced Cytotoxicity via the ROS-Mediated Mitochondrial Pathway and NF-κB/FasL Pathway
- (2014) Xiaoting Jin et al. PLoS One
- Glucocorticoid receptor-dependent immunomodulatory effect of ursodeoxycholic acid on liver lymphocytes in mice
- (2013) Toshimichi Takigawa et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver
- (2013) Jiayin Yao et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Probiotics Prevent Hepatic Encephalopathy in Patients With Cirrhosis: A Randomized Controlled Trial
- (2013) Manish Kumar Lunia et al. Clinical Gastroenterology and Hepatology
- Silibinin ameliorates steatosis and insulin resistance during non-alcoholic fatty liver disease development partly through targeting IRS-1/PI3K/Akt pathway
- (2013) Yongxiang Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Oral Branched-Chain Amino Acids Have a Beneficial Effect on Manifestations of Hepatic Encephalopathy in a Systematic Review with Meta-Analyses of Randomized Controlled Trials
- (2013) Lise L. Gluud et al. JOURNAL OF NUTRITION
- Branched-chain amino acids and muscle ammonia detoxification in cirrhosis
- (2013) Gitte Dam et al. METABOLIC BRAIN DISEASE
- Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trial
- (2013) Enrico Magosso et al. Nutrition Journal
- Alterations in Sulfur Amino Acid Metabolism in Mice Treated with Silymarin: A Novel Mechanism of Its Action Involved in Enhancement of the Antioxidant Defense in Liver
- (2013) Do Kwon et al. PLANTA MEDICA
- Branched-Chain Amino Acids Ameliorate Fibrosis and Suppress Tumor Growth in a Rat Model of Hepatocellular Carcinoma with Liver Cirrhosis
- (2013) Jung Hoon Cha et al. PLoS One
- Lipopolysaccharide Causes an Increase in Intestinal Tight Junction Permeability in Vitro and in Vivo by Inducing Enterocyte Membrane Expression and Localization of TLR-4 and CD14
- (2012) Shuhong Guo et al. AMERICAN JOURNAL OF PATHOLOGY
- Ursodeoxycholic acid stimulates the formation of the bile canalicular network
- (2012) Yuki Ikebuchi et al. BIOCHEMICAL PHARMACOLOGY
- Spirulina platensis versus silymarin in the treatment of chronic hepatitis C virus infection. A pilot randomized, comparative clinical trial
- (2012) Mostafa Yakoot et al. BMC GASTROENTEROLOGY
- Effects of Metformin, Pioglitazone, and Silymarin Treatment on Non- Alcoholic Fatty Liver Disease: A Randomized Controlled Pilot Study
- (2012) Ali Akbar Hajiaghamohammadi et al. Hepatitis Monthly
- Efficacy of rosuvastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label, pilot study
- (2012) Takashi Nakahara et al. HEPATOLOGY RESEARCH
- Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: Analysis of isolated hepatic stellate cells
- (2012) MINA KIM et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Effect of Silymarin (Milk Thistle) on Liver Disease in Patients With Chronic Hepatitis C Unsuccessfully Treated With Interferon Therapy
- (2012) Michael W. Fried JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial–stellate cell deactivation induced by statins
- (2012) Giusi Marrone et al. JOURNAL OF HEPATOLOGY
- miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease
- (2012) Rui E. Castro et al. JOURNAL OF HEPATOLOGY
- Beneficial effect of branched-chain amino acid supplementation on glycemic control in chronic hepatitis C patients with insulin resistance: Implications for type 2 diabetes
- (2012) Yumie Takeshita et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Early administration of branched-chain amino acid granules
- (2012) Toru Ishikawa WORLD JOURNAL OF GASTROENTEROLOGY
- Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: An overview of their mechanisms of action
- (2012) Raoul Poupon Clinics and Research in Hepatology and Gastroenterology
- Effects of Branched-Chain Amino Acids Supplementation in Patients With Cirrhosis and a Previous Episode of Hepatic Encephalopathy: A Randomized Study
- (2011) Iñigo Les et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications
- (2011) Marcelo G. Roma et al. CLINICAL SCIENCE
- Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis
- (2011) Michele Malaguarnera et al. DIGESTIVE DISEASES AND SCIENCES
- Effects of late evening snack including branched-chain amino acid on the function of hepatic parenchymal cells in patients with liver cirrhosis
- (2011) Chizu Koreeda et al. HEPATOLOGY RESEARCH
- Efficacy of pitavastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label, pilot study
- (2011) Hideyuki Hyogo et al. HEPATOLOGY RESEARCH
- Vitamin E and the Risk of Prostate Cancer
- (2011) Eric A. Klein et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antiapoptotic effect of DDB against hepatic ischemia-reperfusion injury
- (2011) Alshaymaa A. El-Bahy et al. JOURNAL OF TOXICOLOGICAL SCIENCES
- Prevention of free fatty acid-induced hepatic lipotoxicity by carnitine via reversal of mitochondrial dysfunction
- (2011) Dae Won Jun et al. LIVER INTERNATIONAL
- Nor-ursodeoxycholic acid reverses hepatocyte-specific nemo-dependent steatohepatitis
- (2010) N. Beraza et al. GUT
- High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial
- (2010) Ulrich F. H. Leuschner et al. HEPATOLOGY
- Effect of an oral branched chain amino acid-enriched snack in cirrhotic patients with sleep disturbance
- (2010) Tatsuki Ichikawa et al. HEPATOLOGY RESEARCH
- Simvastatin modulates the adhesion and growth of hepatocellular carcinoma cells via decrease of integrin expression and ROCK
- (2010) Relja INTERNATIONAL JOURNAL OF ONCOLOGY
- Potential role of branched-chain amino acids in glucose metabolism through the accelerated induction of the glucose-sensing apparatus in the liver
- (2010) Nobito Higuchi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis
- (2010) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial
- (2009) Juan G. Abraldes et al. GASTROENTEROLOGY
- Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
- (2009) P. D. Cani et al. GUT
- Clinical course of alcoholic liver cirrhosis: A Danish population-based cohort study
- (2009) Peter Jepsen et al. HEPATOLOGY
- Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells
- (2009) Marco Trappoliere et al. JOURNAL OF HEPATOLOGY
- Bile acids: regulation of apoptosis by ursodeoxycholic acid
- (2009) Joana D. Amaral et al. JOURNAL OF LIPID RESEARCH
- Effects of ursodeoxycholic acid in combination with vitamin E on adipokines and apoptosis in patients with nonalcoholic steatohepatitis
- (2009) Maria Luisa Balmer et al. LIVER INTERNATIONAL
- A randomized pilot trial of oral branched-chain amino acids in early cirrhosis: Validation using prognostic markers for pre-liver transplant status
- (2009) Etsushi Kawamura et al. LIVER TRANSPLANTATION
- Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice
- (2008) Kosuke Okada et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Silibinin Is a Potent Antiviral Agent in Patients With Chronic Hepatitis C Not Responding to Pegylated Interferon/Ribavirin Therapy
- (2008) Peter Ferenci et al. GASTROENTEROLOGY
- 8-Hydroxy-2′-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection
- (2008) Makoto Chuma et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia
- (2008) Hideyuki Hyogo et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- An Updated Systematic Review with Meta-Analysis for the Clinical Evidence of Silymarin
- (2008) R. Saller et al. FORSCHENDE KOMPLEMENTARMEDIZIN
- Localization of polypyrimidine-tract-binding protein is involved in the regulation of albumin synthesis by branched-chain amino acids in HepG2 cells
- (2007) Masashi Kuwahata et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More